volume 91, issue 5, P675-690 2011
DOI: 10.1038/labinvest.2010.198
View full text
|
Sign up to set email alerts
|
Share

Abstract: In the setting of myocardial infarction (MI), implanted stem cell viability is low and scar formation limits stem cell homing, viability, and integration. Thus, interventions that favorably remodel fibrotic healing may benefit stem cell therapies. However, it remains unclear whether it is feasible and safe to remodel fibrotic healing post-MI without compromising ventricular remodeling and dysfunction. This study, therefore, determined the anti-fibrotic and other effects of the hormone, relaxin in a mouse mode…

Expand abstract